AllogeneiC Human Mesenchymal Stem Cells (hMSC) in Patients With Aging FRAilTy Via IntravenoUS Delivery

NCT02065245 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

65

Enrollment

INDUSTRY

Sponsor class

Conditions

Frailty

Interventions

BIOLOGICAL: Allogeneic Human Mesenchymal Stem Cells (allo-hMSCs)
BIOLOGICAL: Placebo
BIOLOGICAL: Penicillin/Streptomycin-Free Allogeneic Human Mesenchymal Stem Cells (allo-hMSCs)

Sponsor

Longeveron Inc.

Collaborators

[object Object]